Drug Safety and Pharmacovigilance Software Market by Functionality (Fully Integrated Software, Adverse Event Reporting), Delivery Mode (On-demand/Cloud based (SAAS), On-premise), End-user (CROs, Pharma & Biotech Companies, BPOs) – 2019 to 2024

$3,850.00$5,850.00

AVAIL 20% DISCOUNT ON PURCHASE OF ANY REPORT
Published on: May 28, 2019
Clear
SKU: GMS459 Category:

The global market size for drug safety and pharmacovigilance software is set to grow at a CAGR of 6.41% in 2019-2024 and is expected to reach a value of USD211.5 million in 2024. The growth of the global pharmacovigilance and drug safety software market is driven by factors such as the incidence rates of adverse drug reactions (ADRs) and growing adoption of pharmacovigilance software by outsourcing companies.

Drug Safety and Pharmacovigilance Software Market by Functionality (Fully Integrated Software, Adverse Event Reporting), Delivery Mode (On-demand/Cloud based (SAAS), On-premise), End-user (CROs, Pharma & Biotech Companies, BPOs) - 2019 to 2024 1

Drug Safety and Pharmacovigilance Software Market by Functionality (Fully Integrated Software, Adverse Event Reporting), Delivery Mode (On-demand/Cloud based (SAAS), On-premise), End-user (CROs, Pharma & Biotech Companies, BPOs) - 2019 to 2024 2

Drug Safety and Pharmacovigilance Software Market by Functionality (Fully Integrated Software, Adverse Event Reporting), Delivery Mode (On-demand/Cloud based (SAAS), On-premise), End-user (CROs, Pharma & Biotech Companies, BPOs) - 2019 to 2024 3

Drug Safety and Pharmacovigilance Software Market by Functionality (Fully Integrated Software, Adverse Event Reporting), Delivery Mode (On-demand/Cloud based (SAAS), On-premise), End-user (CROs, Pharma & Biotech Companies, BPOs) - 2019 to 2024 4

Drug Safety and Pharmacovigilance Software Market by Functionality (Fully Integrated Software, Adverse Event Reporting), Delivery Mode (On-demand/Cloud based (SAAS), On-premise), End-user (CROs, Pharma & Biotech Companies, BPOs) - 2019 to 2024 5

Drug Safety and Pharmacovigilance Software Market by Functionality (Fully Integrated Software, Adverse Event Reporting), Delivery Mode (On-demand/Cloud based (SAAS), On-premise), End-user (CROs, Pharma & Biotech Companies, BPOs) - 2019 to 2024 6

Drug Safety and Pharmacovigilance Software Market by Functionality (Fully Integrated Software, Adverse Event Reporting), Delivery Mode (On-demand/Cloud based (SAAS), On-premise), End-user (CROs, Pharma & Biotech Companies, BPOs) - 2019 to 2024 7

Drug Safety and Pharmacovigilance Software Market by Functionality (Fully Integrated Software, Adverse Event Reporting), Delivery Mode (On-demand/Cloud based (SAAS), On-premise), End-user (CROs, Pharma & Biotech Companies, BPOs) - 2019 to 2024 8

1 Overview
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3  Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Drug Safety and Pharmacovigilance Software Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Drug Safety and Pharmacovigilance Software Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Drug Safety and Pharmacovigilance Software Market – By Functionality (Market Size –
& million/billion)
8.1 Adverse Event Reporting Software
8.2 Drug Safety Audits Software
8.3 Issue Tracking Software
8.4 Fully Integrated Software

9 Global Drug Safety and Pharmacovigilance Software Market – By Delivery Mode
9.1 On-premise Delivery Mode
9.2 On-demand/Cloud based (SaaS) Delivery Mode

10 Global Drug Safety and Pharmacovigilance Software Market – By End-User
10.1 Pharma and Biotech Companies
10.2 Contract Research Organizations (CROs)
10.3 Business Process Outsourcing (BPO) Firms
10.4 Other

11 Global Drug Safety and Pharmacovigilance Software Market – By Geography (Market Size
– & million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa

12 Global Drug Safety and Pharmacovigilance Software Market – Entropy
12.1 New product launches
12.2 M&A's, collaborations, JVs and partnerships

13 Global Drug Safety and Pharmacovigilance Software Market Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 AB-Cube
13.3 Arisglobal
13.4 Sparta Systems, Inc
13.5 United Biosource Corporation
13.6 Umbra Global
13.7 Extedo GMBH.
13.8 Ennov.
13.9 Online Business Applications, Inc
13.10 Oracle Corporation.
13.11 Sarjen Systems Pvt. Ltd
13.12 Company 11 & more

14 Global Drug Safety and Pharmacovigilance Software Market – Appendix
14.1 Sources
14.2 Abbreviations